Merck, Plaintiffs Bicker Over Fosamax MDL Wind-Down Plans

Law360, New York (August 19, 2013, 7:56 PM EDT) -- Merck & Co. Inc. and the plaintiffs suing the company over jaw injuries allegedly caused by the bone drug Fosamax proposed competing plans for the wind-down of multidistrict litigation on Monday, with the drugmaker claiming its opponents seek to “dump” the cases across the country.

Merck and the plaintiffs' steering committee sent a joint letter to U.S. District Judge John Keenan outlining their proposals for the transfer of the remaining cases in the litigation, as the judge requested during a status conference last week. He said...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.